Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamide injection: results of a multicenter phase II trial. [electronic resource]
Producer: 20001214Description: 651-60 p. digitalISSN:- 1053-1807
- Adenocarcinoma -- diagnosis
- Administration, Rectal
- Adult
- Aged
- Biopsy, Needle
- Chi-Square Distribution
- Contrast Media
- Dose-Response Relationship, Drug
- Female
- Ferric Compounds
- Gadolinium DTPA
- Humans
- Image Processing, Computer-Assisted
- Injections, Intravenous
- Magnetic Resonance Imaging -- methods
- Male
- Middle Aged
- Neoplasm Staging -- methods
- Preoperative Care
- Probability
- ROC Curve
- Rectal Neoplasms -- diagnosis
- Sensitivity and Specificity
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.